MedTrace Logo

Quantitative MR Biomarkers for Sarcoma Treatment

NCT01017978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2015-12-04

No results posted yet for this study

Summary

To determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used.

Conditions

  • Soft Tissue Tumors

Interventions

PROCEDURE

MRI Scan of soft tissue tumor

MRI scan will be completed at baseline (prior to start of subject's clinically ordered chemotherapy treatments.

Sponsors & Collaborators

Principal Investigators

  • Gary Luker, M.D. · Universityof Michigan Health Systems

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-12-31
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017978 on ClinicalTrials.gov